ferrioxamine B

Subscribe to Selected New Research on ferrioxamine B

13 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: RN given refers to parent cpd; structure

Also Known As:

ferrioxamine; ferrioxamine B mesylate; ferrioxamine B, 55Fe-labeled; ferrioxamine B, monomethanesulfonate salt; (N-(5-(3-((5-aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(N-hydroxyacetamido)pentyl) carbamoyl)propionohydroxamato(3-))iron

Bio-Agent Context: Research Results

Organic Chemicals: 40

Organometallic Compounds: 5

Ferric Compounds: 4

ferrioxamine B: 13

Inorganic Chemicals: 5

Iron Compounds: 46

Ferric Compounds: 4

ferrioxamine B: 13

Related Diseases

1.	Chronic Kidney Failure (Chronic Renal Failure) 01/01/1994 - "We assessed the pharmacokinetics of aluminoxamine and ferrioxamine in dogs with sustained intermittent bile duct ligation and either normal renal function or stable chronic renal failure" 04/29/1988 - "We have studied the pharmacokinetics of desferrioxamine (DFA), ferrioxamine (FeA) and aluminoxamine (AlA) in patients with chronic renal failure on continuous ambulatory peritoneal dialysis (CAPD) after 10 mg/kg (15.24 mumol/kg) body weight desferrioxamine (DESFERAL) administration by intramuscular and intraperitoneal routes" Get all the results and reference details, order at left...
2.	Body Weight (Weight, Body) 01/01/1991 - "Preliminary experiments in three dogs under invasive cardiovascular monitoring demonstrated that high-dose bolus application (0.1-0.3 mmol/kg body weight) of ferrioxamine-B leads to a precipitous blood pressure drop to almost zero, lasting for several minutes" 04/29/1988 - "We have studied the pharmacokinetics of desferrioxamine (DFA), ferrioxamine (FeA) and aluminoxamine (AlA) in patients with chronic renal failure on continuous ambulatory peritoneal dialysis (CAPD) after 10 mg/kg (15.24 mumol/kg) body weight desferrioxamine (DESFERAL) administration by intramuscular and intraperitoneal routes" Get all the results and reference details, order at left...
3.	Renal Insufficiency 01/01/1991 - "The most serious of these include hypotension, renal insufficiency, neurotoxicity, growth retardation and opportunistic infections: some of these side effects may be attributed to or aggravated by ferrioxamine" Get all the results and reference details, order at left...
4.	Zygomycosis (Phycomycosis) 01/01/1993 - "rhizopodiformis (isolated from a dialysis patient who died of zygomycosis while on desferrioxamine therapy) was studied in an iron-deficient medium (1) with human serum at increasing concentrations and (2) with 40% human serum in the presence of ferrioxamine at different concentrations" Get all the results and reference details, order at left...
5.	Iron Overload 01/01/1992 - "We investigated the pharmacokinetics of desferrioxamine and its chelated compounds aluminoxamine and ferrioxamine in normal volunteers and haemodialysis patients with and without iron overload" Get all the results and reference details, order at left...
16 Diseases and 13 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Deferoxamine (Desferal)
2.	Iron (Serum Iron Level)
3.	aluminoxamine
4.	Hydroxamic Acids (Hydroxamic Acid)
5.	Furosemide (Lasix)
6.	Pentetic Acid (DTPA)
7.	yersiniabactin
7 Drugs and Important Bio-Agents and 11 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Continuous Ambulatory Peritoneal Dialysis (CAPD)
2.	Ligation
2 Therapies and Procedures and 2 more articles analyzed in the Research Interface, order at left...

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>